How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG?
Year of publication: |
2021
|
---|---|
Authors: | Dintsios, Charalabos-Markos ; Chernyak, Nadja |
Published in: |
Applied Health Economics and Health Policy. - Cham : Springer International Publishing, ISSN 1179-1896. - Vol. 20.2021, 3, p. 287-290
|
Publisher: |
Cham : Springer International Publishing |
Subject: | Pharmacoeconomics and Health Outcomes | Quality of Life Research | Health Economics | Health Administration | Public Health |
-
Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data
Wendl, Johannes, (2023)
-
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients
Böhm, Anna-Katharina, (2022)
-
Büssgen, Melanie, (2023)
- More ...
-
Dintsios, Charalabos-Markos, (2017)
-
Dintsios, Charalabos-Markos, (2024)
-
A new prize system for drug innovation
Gandjour, Afschin, (2011)
- More ...